Imago BioSciences, Inc.
DelistedCIK 1623715fmd_1GH00SBF5V7NYMJ3R9JKQAPEFEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2022, 11 periods
| Line item | FY2020 | FY2021 |
|---|---|---|
| Research and development | 15 | 32 |
| Total operating expenses | 18 | 43 |
| Operating income | (18) | (43) |
| Other non-operating income (expense) | 0 | 0 |
| Income before taxes | (18) | (42) |
| Income tax expense | 0 | 0 |
| Net income from continuing operations | (18) | (42) |
| Net income | (18) | (42) |